Buzzing Stocks

HDFC AMC, RBL Bank Share Price Touches 52-week Highs; Suzlon Energy Shares Jump 2.57%

HDFC AMC, RBL Bank Share Price Touches 52-week Highs; Suzlon Energy Shares Jump 2.57%

HDFC AMC and RBL Bank shares touched 52-week highs during trading session on Tuesday. HDFC AMC closed the trading session near highs.

BIOCON, Tata Elxsi, IndusInd Bank Share Price Jumps; Technical Charts Suggest Bullish Trends

BIOCON, Tata Elxsi, IndusInd Bank Share Price Jumps; Technical Charts Suggest Bullish Trends

Biocon Share price was trading 2.7 percent higher today and the stock is looking bullish on technical charts. Biocon could also see a fresh 52-week high in the coming sessions.

Mankind Pharma, Laurus Labs, and PAYTM Share Price Jumps; Bullish Breakout on Technical Charts

Mankind Pharma, Laurus Labs, and PAYTM Share Price Jumps; Bullish Breakout on Technical Charts

Mankind Pharma, Laurus Labs, and PAYTM share prices are currently in bullish breakout on technical charts. Mankind Pharma was trading 4.2 percent higher at the time of publication of this report.

RBL Bank Share Price Jumps 3.28%; Stock Looks Bullish on Technical Charts with Resistance at Rs 275

RBL Bank Share Price Jumps 3.28%; Stock Looks Bullish on Technical Charts with Resistance at Rs 275

RBL Bank share price jumped 3.28 percent on Friday. The private banking counter has been trading close to its yearly highs and technical charts suggest strong momentum in the stock.

Ramco Cements, Asahi India Glass, Glenmark Pharmaceuticals Share Price Touches Yearly Highs; Technical Charts Suggest Bullish Outlook

Ramco Cements, Asahi India Glass, Glenmark Pharmaceuticals Share Price Touches Yearly Highs; Technical Charts Suggest Bullish Outlook

Ramco Cements, Asahi India Glass and Glenmark Pharmaceuticals shares were among major gainers on Friday.

Glenmark Pharmaceuticals Share Price Jumps 14% on Abbvie Deal; Bullish Breakout on Technical Charts

Glenmark Pharmaceuticals Share Price Jumps 14% on Abbvie Deal; Bullish Breakout on Technical Charts

Glenmark Pharmaceuticals has seized the spotlight within India’s pharmaceutical landscape, propelled by a record-breaking global licensing agreement for its flagship oncology asset.

Pages